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Abstract
According to the Global Information System on Alcohol and Health (GISAH),
alcohol consumption causes more than 2.5 million deaths annually. This organization
also attributes more than sixty different diseases in which alcoholism plays a significant
role. Such diseases include the Human Immunodeficiency Virus (HIV) and Acquired
Immune Deficiency Syndrome (AIDS) (WHO, 2014). There are over 50,000 new cases
of HIV reported each year. In the United States, it is estimated that more than 1.1 million
people are infected with HIV, and about one in six people are completely unaware that
they are infected (CDC.gov, 2013). A systematic literature review was done on twenty
different studies to see the effects that the consumption of alcohol may have on adherence
to highly active antiretroviral therapy (HAART) and the progression of HIV. This
literature review examined these effects by looking at CD4+ cell levels, viral load,
disease progression, and early mortality rates. In the results, it was shown that there may
be a possible correlation between the consumption of alcohol and HAART nonadherence, as well as the consumption of alcohol causing disease progression and early
death. This review also found that several different studies considered HAART nonadherence to be a multifactorial issue, which should be further researched to help with the
treatment of HIV. In conclusion, an assessment of the consumption of alcohol should be
done in all patients diagnosed with HIV/AIDS. Patient teaching is needed to teach about
the possible effects that alcohol may have on HAART, and referral to support groups is
needed to help with adherence to HAART therapy. Prevention strategies should be
formed to help decrease the spread of HIV/AIDS in the United States.
Key Terms: HIV/AIDS, Alcohol consumption, highly active antiretroviral
therapy, disease progression, adherence, and non-adherence
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Chapter One: Introduction
The consumption of alcohol during antiretroviral therapy may lead to medication
non-adherence. Non-adherence could lead to both the progression and spread of
HIV/AIDS. (Samet et al., 2004). When moderate amounts of alcohol are consumed, it can
block the absorption of antiretroviral medications in the stomach. When the absorption is
blocked, the patient receives an inadequate amount of the medication thereby reducing
effectiveness of the antiretroviral medication. The consumption of alcohol can also block
the metabolism of the antiretroviral medication in the liver. When the metabolism of the
anti-retroviral is blocked in the liver, the medication stays in the system longer causing
toxicity or increasing side effects. When a patient exhibit sides effects of medication they
are more likely to skip doses, or discontinue the medication which can lead to nonadherence (Wilson, 1995). Since alcohol is an immunosuppressant, the consumption of
alcohol among patients infected with HIV/AIDS taking HAART may increase their
susceptibility to opportunistic infections (Baum et al., 2010). Lastly, when consuming
large amounts of alcohol, the growth rate of HIV increases causing a viral overload and a
decrease in CD4+ cells (Wilson, 1995).
Since the creation of HAART therapy in 1996, there have been developments in
both the immune and viral outcomes in the treatment of HIV. In addition, both the life
span and the quality of life have been increased in patients who are infected with
HIV/AIDS. However, in order for the benefits of HAART to be achieved, patients must
adhere to the medication regimen. The consumption of alcohol has been related with
HAART non-adherence in multiple studies, yet the characteristics of the correlation are
still vague and further research is still needed (Hendershot et al., 2009).
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It was in the 1980's when the consumption of alcohol increased, and today a little
over five liters per adult person is consumed every year worldwide. According to Baum
et al. (2010), alcohol abuse was the third leading cause of death in 2007, with
approximately five percent of the population drinking heavily and fifteen percent of the
population binge drinking. The consumption of alcohol is common in populations
infected with HIV/AIDS. Some studies show a prevalence of alcohol abuse of up to fifty
percent in patients infected with HIV/AIDS (Baum et al., 2010).
During the release of HAART therapy, the research of the relationship between
the consumption of alcohol and the disease progression of HIV was not adequately
researched. The focus was placed on treating patients with this newly developed
medication rather than looking at the possible effects of alcohol on patients infected with
HIV/AIDS. The effects of alcohol and HARRT therapy was not considered at this time
(Samet et al., 2003). There are several studies on the consumption of alcohol and HIV
disease progression that came about after the introduction of HAART. According to
Baum et al. (2010), these studies established that alcohol results in an increase in the viral
load, a decrease in CD4+ cells, and a decrease in adherence to HAART (Baum et al.,
2010). This systematic literature review will look at research dealing with alcohol
consumption and its relationship to the progression of HIV and adherence to HAART
therapy.
Problem Statement:
Patients who are infected with HIV or AIDS must adhere to their medications
regime in order to prevent the progression of HIV. They must also keep viral load levels
low which decrease the effects of the virus on the body thereby decreasing complications
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of the disease (AIDS.gov, 2012). Alcohol is a potential issue with antiretroviral
medications because it is thought to affect patients negatively (Kalichman, 2009).
According to Manuela et al. (2012), there is research that reports that alcohol
consumption leads to the resistance of HAART, co-morbidity, and an increase in
mortality rates. Given the spread of HIV/AIDS in the United States, the research shows
that alcohol may negatively affect HAART compliance thereby causing non-adherence
and subsequence progression of the disease.
Purpose of the Study:
The purpose of this study was to perform a systematic literature review of
numerous research articles that examine the effects of alcohol on HIV/AIDS patients
taking HAART. This review also explored research related to alcohol consumption as a
catalyst leading to the progression of HIV/AIDS in patients who consume alcohol while
prescribed anti-retroviral therapy. A descriptive correlational design was used.
This study could become the catalyst for future research to understand how to prevent
the rise and spread of HIV/AIDS in patients who drink alcohol while taking HAART.
Hopefully, the management of HIV and AIDS patients receiving HAART therapy will be
improved.
Research Questions:
Research Question 1: Is there a correlation between alcohol consumption and
HAART non-adherence?
Hypothesis 1
H1: There is a positive correlation between alcohol consumption and HAART adherence
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H0: There is not a positive correlation between alcohol consumption and HAART
adherence
Research Question 2: Doses alcohol consumption play a role in the disease
progression of HIV?
Hypothesis 1
H1: Alcohol consumption does play a role in the disease progression of HIV?
H0: Alcohol consumption does not play a role in the disease progression of HIV?
Definition of Terms:
Human Immunodeficiency Virus is a virus that can only be acquired by humans.
This virus attacks and destroys the CD4+ cells in the body, which leads to a weakened
immune system. Patients with HIV will have a CD4+ cell count less than 500 cells/mm3
(AIDS.gov, 2012).
Acquired Immunodeficiency Syndrome is an acquired syndrome because it is
acquired after birth. Also, it is named a syndrome because it is a complex disease that has
a range of different complications and symptoms. Patients with AIDS will have a CD4+
cell count less than 200 cells/mm3 (AIDS.gov, 2012).
A viral load is the quantity of HIV in the patient's blood. Antiretroviral
medications are used to treat symptoms of HIV/AIDS by lowering the viral load in the
body (AIDS.gov, 2012). The viral load and the CD4+ cells count are directly correlated
when the viral load is high the CD4+ cell count is low and vice versa. (U.S. Department
of Veteran Affairs, 2013).
CD4+ cells are the cells that send signals to activate the body's immune response
when foreign bodies such as viruses or bacteria have entered the body. The CD4+ cells
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are otherwise known as T-cells, and these are the cells that fight off infections and
diseases in the body (AIDS.gov, 2012).
Opportunistic infections are infections that take advantage of weakened immune
systems that cause severe illnesses (U.S. Department of Veteran Affairs, 2013). If
patients have more than one opportunistic infection, they will be diagnosed with AIDS
regardless of their CD4+ cell count (CDC.gov, 2013). Opportunistic infections are
infections such as Tuberculosis, Candidiasis, and Histoplasmosis (AIDS.gov, 2012).
For the purpose of this study, adherence will refer to HIV/AIDS patients, who are
prescribed antiretroviral medication and are taking the medication as prescribed. Nonadherence will refer to HIV/AIDS patients who are prescribed antiretroviral medication
and purposely skip or forget to take prescribed medications as prescribed. Non-adherence
can lead to the resistance of prescribed medications. If a patient becomes resistant to
prescribed medication, the medication no longer works for a patient infected with
HIV/AIDS. Resistance happens when the body creates a mutated strain of the virus that
does not respond to the medication. When the patient becomes resistant to medications,
the virus is no longer impeded from multiplying which results in a higher viral load and
progression of the disease (U.S. Department of Veteran Affairs, 2013).
Many studies that examine alcohol consumption in patients infected with
HIV/AIDS use the categories of: (a) non-drinkers or abstainers, (b) hazardous drinkers or
binge drinkers, and (c) non-hazardous drinkers or non-binge drinkers. Non-drinkers or
abstainers are those who do not consume any alcohol. Hazardous drinkers or binge
drinkers are those who consume more than five drinks on the day that they consume
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alcohol. Non-hazardous drinkers or non-binge drinkers are those that consume less than
five drinks on the day they consume alcohol (Braithwaite et al., 2007).
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Chapter Two: Literature Review
Alcohol Consumption and HAART:
After HAART became the treatment of choice for HIV/AIDS, studies began to
examine the effects of certain factors that affect HAART such as the consumption of
alcohol. According to Baum et al. (2010), such studies established that alcohol results in
an increase in the viral load, a decrease in CD4+ cell levels, and a decrease in adherence
to HAART (Baum et al., 2010). This systematic literature review examined the results of
these studies.
According to Miguez et al. (2003), a cross-sectional analysis of HIV-infected
drug users found that patients who consumed alcohol four or more times per week and
who were receiving HAART, were four times less likely to achieve a reduced viral load
and two times more likely to have CD4+ cell count below 500 cell/mm³ than moderate
drinkers or abstainers (as cited in Baum et al., 2010).
According to Fabris et al. (2000), a small prospective study of patients infected
with HIV taking HAART, found that there was no difference in those who attained a
reduced viral load or decreased CD4+ cell count between heavy alcohol drinkers,
moderate alcohol drinkers, and abstainers (as cited in Baum et al., 2010). However, a
larger longitudinal study of patients infected with HIV with a history of alcohol problems
found that the consumption of alcohol was significantly correlated with a decreased
adherence to HAART and was negatively related with HIV viral load suppression (Samet
et al., 2004). Also, according to Howard et al. (2002), a prospective study of 161 patients
infected with HIV on ART found that poor adherence to HAART was considerably
related to the consumption of alcohol (as cited in Baum et al., 2010).
7

According to Baum et al. (2010), the findings suggest that the consumption of
alcohol may accelerate the progression of HIV through poor adherence to HAART.
However, a seven-year prospective study on the relationship between heavy alcohol
consumption and lower CD4+ cell counts in a cohort with HIV-positive patients not on
HAART indicates that the consumption of alcohol may directly influence the progression
of HIV through an effect on the CD4+ cell count (Samet et al., 2007). All patients with
HIV or AIDS are treated with antiretroviral therapy. Anti-retroviral therapy is used to
suppress the replication of the virus thereby improving the immune system. It is also used
to increase the number of CD4+ cells which helps protect patients from opportunistic
infections (Manuela et al., 2012).The goal of the treatment is to have positive outcomes,
which will require close adherence to the medication regimen. If non-adherence occurs,
then the virus can replicate and develop resistance, which can affect the patient
negatively (Kalichman et al., 2009).
HIV/AIDS
There is no cure for HIV/AIDS. Taking medications for the treatment of
HIV/AIDS is important because it can control symptoms and slow down the progression
of the disease (AIDS.gov, 2012). However, the medications can only work if they are
taken and taken correctly. The history of non-adherence to HIV/AIDS medications is a
major problem. There are many reasons for medication non-adherence. However, but
according to the research, alcohol consumption could be a major causative factor in
medication non-adherence in patients with HIV/AIDS. According to Cook et al. (2001), it
was found that nineteen percent of HIV-infected patients reported a drinking problem.
Also, according to Cook et al. (2001), it was shown the compared with non-problem
8

drinkers, problem drinkers were more likely to take HAART off schedule (Cook et al.,
2001).
In the United States, it is estimated that more than 1.1 million people are infected
with HIV, and about one in six people are completely unaware that they are infected
(CDC.gov, 2013). Human Immunodeficiency Virus has been traced back to a type of
chimpanzee in West Africa (AIDS.gov, 2012). Scientists have identified these
chimpanzees to be the source of infection found in humans (CDC.gov, 2014). Scientists
believe that the simian immunodeficiency virus (SIV), the chimpanzee type of
immunodeficiency virus was transmitted to humans where it transformed into HIV. It is
believed that humans probably came in contact with the virus as far back as the 1800's by
coming in contact with the infected blood from the chimpanzees when they hunted and
ate them (AIDS.gov, 2012). Human immunodeficiency virus then spread slowly from
Africa to other parts of the world. The virus has been in the United States since the mid to
late 1970's (CDC.gov, 2014).
Human immunodeficiency virus can be found in many specific human body
fluids, so patients become infected once HIV-infected fluids enter the body (CDC.gov,
2014). Fluids that contain high levels of HIV are blood, semen, pre-seminal fluid, breast
milk, vaginal fluids, and rectal mucous. These fluids can be transmitted by sexual
contact, pregnancy, childbirth, breastfeeding, intravenous drug use, occupational
exposure, a blood transfusion, and even through an organ transplant (AIDS.gov, 2012).
These fluids must come in contact with a mucous membrane, damaged tissue, or be
directly injected into the blood stream by needle or syringe for the transmission of HIV to
occur (CDC.gov, 2014).
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Human immunodeficiency virus in the United States is mainly spread by having
sex that is unprotected (CDC.gov, 2014). During sexual contact, whether it be oral, anal
or vaginal, a person can come into contact with HIV infected body fluids. The body
fluids can transmit the virus through the bloodstream through tiny cuts in the delicate
linings of the vaginal canal, vulva, penis, rectum, and even the mouth (AIDS.gov, 2012).
Anal sex has the highest risk of transmission while vaginal sex is the second-highest risk
of transmission (CDC.gov, 2014). Patients can be diagnosed as HIV positive by taking
two tests, a preliminary enzyme immunoassay (EIA) test and a confirmatory Western blot
test. If these tests are positive, it means the patient is HIV-positive. This means that it is
possible for them to pass the virus to others (AIDS.gov, 2012). Just because a patient
receives a negative test result, does not mean they are not HIV positive. A negative test
result can appear depending on when the patient may have been exposed to HIV
(CDC.gov, 2014).
Once patients are diagnosed with HIV, it means that their CD4+ cell count is less
than 500 cells/mm³. A normal CD4+ cell count is 800-2500 cells/mm³. When the CD4+
cell count reaches 350 cells/mm³ or below treatment needs to be started because the
person is at risk for opportunistic infections. When a patient becomes infected with AIDS
or the third stage of HIV, their CD4+ cell count will be below 200 cells/mm³. To slow the
progression of HIV/AIDS and to treat the symptoms of HIV/AIDS, patients must take
HAART (AIDS.gov, 2012).
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Chapter Three: Methodology
Purpose and Research Design:
The purpose of this study was to perform a systematic literature review to
examine the effects of the consumption of alcohol on patients infected with HIV/AIDS
taking HAART. A systematic literature review was performed to find a more conclusive
answer of how alcohol consumption affects patients infected with HIV/AIDS and
prescribed HAART. The literature review encompassed research published in the United
States during the years 2001-2012. It observed both men and women age eighteen and
older, who were infected with HIV or AIDS, and who consume alcohol while taking
HAART.
Data Collection
In the systematic literature review, a database search using Academic Search
Premier, PubMed, Medline, Scopus, and Cinahl was done. Key terms used included;
HIV/AIDS, Alcohol consumption, highly active antiretroviral therapy, disease
progression, adherence, and non-adherence. The search was then narrowed by making
sure it was peer-reviewed articles and by using the specific term "United States", so that
no articles outside of the United States were pulled up. The research articles were then
reviewed to see if they fulfilled the requirements or criteria.
Criteria
The criteria that were used for this research process was that all studies reviewed
must consist of patients age eighteen years or older. Subjects could be female or male.
The subjects included needed to have consumed alcohol while taking HAART. All
studies must have been done within the United States. Also, each study needed to include
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topics that look at the relationship between HIV/AIDS, alcohol consumption, and highly
active anti-retroviral therapy.
By using the criteria as a guide, this researcher then searched extensively for
studies that met all the criteria and requirements. This assisted with the decision of
inclusion or exclusion of the different studies for the systematic literature review. The
quality of each study was then determined by the strength of each article. A summary of
each study was then done in order to explore the differences between each of the studies,
to identify patterns among each of the study results, any contrast of results, or other
relationships that may arise within the studies.
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Chapter Four: Results
Effects of Alcohol on Adherence
In the following studies, it is seen that the consumption of alcohol may have an
effect on adherence to HAART therapy in patients with HIV. The results of the
Systematic Literature Review are summarized in Table 1.
In the first study chosen, the relationship between the consumption of alcohol and
adherence to HAART therapy was researched through an observational study at eight
different sites for HIV-positive veterans in a Veterans Aging Cohort Study. In this study,
telephone surveys were performed to see if non-adherence to HAART therapy was
associated with alcohol consumption. A total of 2,702 HIV-positive veterans were
chosen. Of those the veterans chosen, 1,582 did not drink alcohol, 931 veterans were nonbinge drinkers or non-hazardous drinkers, and 239 veterans were hazardous drinkers or
binge drinkers. The veterans who abstained from alcohol missed medications only a little
over two percent on the days surveyed. Non-hazardous drinkers or non-binge drinkers
missed medications three and a half percent on days surveyed, and binge or hazardous
drinkers missed medications eleven percent on surveyed days. Overall, the results of this
study show that there may be an association between the consumption of alcohol and
non-adherence in HAART therapy (Braithwaite et al., 2005).
In a cross-sectional analysis of 1,529 HIV-positive veterans, the association of
alcohol and non-adherence to HAART therapy is researched by looking as far back as
thirty days for drinking histories. This was done to find out adherence practices when
drinking alcohol by performing telephone interviews. Within this study, it was realized
through the telephone interviews that significant non-adherence was correlated with
13

consuming alcohol because patients who had at least two alcoholic drinks were nonadherence to their antiretroviral therapy. Anything over two alcoholic drinks showed
significant non-adherence with patients taking HAART (Braithwaite et al., 2008).
In an observational clinical cohort of 1,711 HIV-positive patients, adherence
practices to HAART when consuming alcohol was researched. In this study, patients
partook in 5,028 interviews with ten percent of the patients being hazardous or binge
drinkers and forty-five percent of the patients consuming alcohol in general. Hazardous
or binge drinkers had a thirty-five percent decrease in adherence to HAART therapy
compared to those patients who did not drink any alcohol. It can be seen in the results of
this study that a high correlation exists between the consumption of alcohol and HAART
non-adherence (Chander et al., 2006)
Another study searching for a correlation between alcohol and non-adherence to
HAART therapy was done in a cross-sectional survey. In this cross-sectional survey,
seventy-five HIV positive patients were given questionnaires at ten different sites. Over
eleven percent of patients stated they missed at least one dose of HAART the day before,
and over seventeen percent said they missed at least one dose of HAART two days before
the interview. Patients in this study had multiple reasons for missing doses with sixty-six
percent forgetting to take the dose altogether, and fifty-three percent being too busy to
take HAART. Overall, all patients were more likely to consume alcohol or were taking
drugs at the time of the study. In this particular study, multiple factors were suggested as
being the reason for non-adherence to HAART therapy (Chesney et al., 2000).
In the next study, a Cross-sectional survey with 212 HIV-positive patients was
done at two different outpatient clinics. At these two different sites, patients reported
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their adherence to HAART through surveys. Results from the surveys showed nineteen
percent had reported hazardous or binge drinking during the last month. Fourteen percent
had reported missing a dose or more within the last day, and thirty percent of the patients
did not adhere to the time medications were scheduled during the last week. Among all
patients who drank, hazardous drinkers or binge drinkers were more likely to miss a dose
and take HAART off schedule with seventeen percent being binge drinkers and fifteen
percent being hazardous drinkers. According to Cook et al. (2001), non-adherence to
HAART therapy was associated with hazardous drinking or binge drinking because
hazardous drinkers or binge drinkers were most likely to report non-adherence to
HAART (Cook et al., 2001).
In a prospective cohort study with a total of 140 HIV-positive patients on
HAART, medication adherence was checked every four weeks at a county HIV clinic.
This was achieved by doing pill counts and through patients self-report to the clinic. The
patients who reported drinking alcohol were adherent to sixty-six percent of the doses
compared to being adherent seventy-four percent of the time like non-drinkers. Also, it
was shown that patients who used pill boxes or timers as an aid to take doses took
seventy-eight percent of the doses compared to taking sixty-six percent of doses with no
help from timers or pill boxes (Golin et al., 2002).
In another study, a meta-analysis was done with over 25,000 HIV positive
patients in over forty different studies. A literature review was performed to find a
correlation between the consumption of alcohol and non-adherence to HAART. In the
results, those who consumed alcohol were only between fifty to sixty percent adherent to
HAART therapy compared to patients who abstained from drinking and were ninety-five
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percent adherent to HAART therapy. In this study, non-adherence to HAART was
strongly correlated with the consumption of alcohol in patients with HIV (Hendershot et
al., 2009).
In a cross-sectional study of 659 HIV-positive patients, patients were randomly
selected from fourteen different sites. Patients were asked questions about alcohol use in
the past month, and CD4+ cell levels and viral load levels were pulled from the clinical
database. Over forty-two percent of the patients reported alcohol use in the last four
months while on HAART. Patients who were hazardous drinkers or binge drinkers
presently were more likely to be non-adherent than former binge drinkers or hazardous
drinkers and patients who abstained from consuming alcohol altogether. Being a former
drinker did not affect adherence at all, and current drinkers were more non-adherent to
HAART (Hicks et al., 2007).
In a longitudinal random control trial, 224 HIV-positive patients were used to see
if the consumption of alcohol was associated with non-adherence to HAART. In this
study, adherence to HAART was checked at two weeks, three months, six months, and
nine months at an outpatient HIV clinic through a medication adherence questionnaire.
Also, alcohol consumption was checked through an alcohol use disorder identification
test. The findings of this study showed that alcohol negatively impacted adherence to
HAART therapy at each checkpoint except at three months. It was shown that social
support helped with adherence. Overall, social support with taking medications could
help with the negative impacts of alcohol use on adherence to HAART therapy (Lehavot
et al., 2011).
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In another study, a prospective cohort of 695 HIV-positive patients in an urban
clinic was performed. Patients in this study completed surveys that addressed both
adherence to HAART and consumption of alcohol. Patients who went from not drinking
to consuming hazardous amounts of alcohol were seen to be less adherent than those
patients who were hazardous drinkers and stopped drinking during HAART therapy.
Also, patients who went from not drinking to consuming hazardous amounts of alcohol
had an increase in CD4+ cell levels (Lucas et al., 2002).
In another study, cross-sectional data was pulled from a prospective observational
cohort using fifty-two women with children to investigate their adherence to HAART
therapy. Adherence was checked using a questionnaire given to the mothers to see what
may be causing their non-adherence to HAART. Within their questionnaires, researchers
found adherence rates to be from forty-three percent to fifty-six percent. It was found that
many different factors lead to the poor adherence rates. These factors included alcohol
consumption, stress from motherhood, and things such as having a partner or having
inadequate beliefs about the benefits of HAART therapy. This study shows that alcohol
could be a part of multiple factors that lead to non-adherence making it a multi-factorial
problem that should be further researched (Murphy et al., 2002).
In a prospective cohort, 349 patients who were HIV positive were given surveys
to fill out at six month intervals. Interviews were used to evaluate adherence to HAART
in the 267 patients who were on HAART. When it came to correlating the consumption
of alcohol and adherence to HAART, the patients on HAART seemed to be less adherent
when consuming alcohol, but when abstaining from alcohol, adherence to HAART was
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increased. The results of the study showed that any amount of alcohol consumed was
associated with a decrease in adherence (Samet et al., 2004).
In a prospective cohort, 1,910 HIV-positive patients reported adherence rates to
HAART therapy for four weeks prior to the survey. Non-adherence to HAART therapy
was reported to be related to multiple factors such as psychiatric disorders, drug use, and
alcohol use. In regards to alcohol consumption, patients who did drink alcohol were more
likely to be non-adherent compared to the patients who did not drink. This study showed
that non-adherence to HAART therapy can be multifactorial, but it still ties alcohol
consumption in with non-adherence (Tucker et al., 2003).
Effects of Alcohol on Disease Progression
Of the literature chosen, it is shown that there were additional effects of alcohol
on patients infected with HIV while taking HAART. There was a decrease in CD4+ cells
that could lead to the progression of HIV. Baum et al. (2010) performed a prospective
longitudinal study on a cohort of 231 HIV-infected patients. Frequent alcohol
consumption was seen to be a factor in the decrease of CD4+ cells in patients who used
antiretroviral therapy. In this particular study, the patients were followed for thirty
months, and biannually blood was drawn to analyze the CD4+ cell count and viral load.
The results of the study showed that frequent alcohol users who drank two or more drinks
daily were about 2.91 times more likely to present with a decline of CD4+ cell levels to
less than or equal to 200 cells. Also, frequent alcohol consumption was associated with a
higher viral load, even in patients who were receiving HAART. These results show that
the consumption of alcohol may have an effect on CD4+ cells and the viral loads leading
to the progression of HIV in patients who are on ART (Baum et al., 2010).
18

A large observational cohort of 2,702 HIV positive patients was done to show an
association with consuming alcohol and HIV disease progression. To show the effects of
alcohol consumption on survival in patients with HIV, a computer simulation was used.
The computer simulation was able to show the impact alcohol has on HAART, and on the
survival in patients who are HIV positive. It showed that patients who consume
hazardous amounts of alcohol were more non-adherent compared to patients who
consumed non-hazardous amounts of alcohol. The results showed that patients who were
non-hazardous drinkers or non-binge drinkers had a reduction in their life expectancy by
more than a year if they drank at least once a week. Patients who drank daily had a
decreased life expectancy by about three years. For hazardous drinkers or binge drinkers
life expectancy was decreased by more than three years if alcohol was consumed at least
once a week, and life expectancy was decreased by about six years if they consumed
hazardous amounts of alcohol every day (Braithwaite et al., 2007).
In a prospective cohort of 881 HIV-positive veterans, the correlation between the
progression of HIV and alcohol consumption was researched at three different HIV
clinics. In this study, patients were given surveys related to their consumption of alcohol.
The alcohol use disorder identification test was also used. The results determined that
twenty percent were hazardous drinkers, and thirty-three percent were binge drinkers. It
was also found that veterans with alcohol consumption problems were associated with
complications such as disease progression, abnormal alanine transaminase or aspartate
transaminase levels, anemia, and multiple hepatic diseases. In this study, alcohol seemed
to be correlated with comorbidities and disease progression of HIV, which can lead to
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early mortality in patients who consume alcohol while taking HAART (Conigliaro et al.,
2003).
In a secondary analysis of a longitudinal cohort, 197 HIV positive patients were
used to see if there was a correlation between the consumption of alcohol and the disease
progression of HIV. In this study, patients were interviewed every six months for a total
of seven times. Patients were asked about alcohol consumption for the past month and
were also given breathalyzer tests before the interview started. Also, patients were to give
a report on their adherence to HAART by reporting how many pills were taken daily
compared to how many were prescribed. In the results, there was evidence that alcohol
negatively affected adherence to HAART. It was shown that patients who consumed
alcohol were not completely adherent to HAART, and had higher HIV RNA levels
compared to those patients who did not drink. The rise in HIV RNA levels could result in
the progression of HIV in patients who consume alcohol while taking HAART (Finucane
et al., 2007).
In an observational clinical cohort, 1,030 HIV-positive women were used to
associate the consumption of alcohol with adherence to HAART therapy. The time of
death was correlated using the Kaplan-Meier statistics and Cox proportional hazards
regression. In this study, it was found that twenty-nine percent of patients occasionally
drank, seventeen percent were hazardous drinkers, and thirteen percent were past
drinkers. Also, through the Cox proportional hazards regression model, HIV-positive
patients who were hazardous drinkers were more likely to have an earlier death compared
to patients who abstained from alcohol (Neblett et al., 2011).
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In another study, a cross-sectional analysis was done on 349 HIV-positive patients
whom all had histories of drinking alcohol. Patients were interviewed and given
questionnaires, and CD4+ cell levels and viral load levels were reviewed in the medical
record. In the results, patients who were moderate or hazardous drinkers had high HIV
RNA levels and lower CD4+ levels compared to those patients who did not drink.
Overall, with lower CD4+ levels and higher HIV RNA levels, patients who were drinking
moderate to hazardous levels of alcohol are more likely to see a progression in HIV than
those patients who did not drink (Samet et al., 2003).
In a prospective Cohort, 595 HIV-positive patients were checked up for a total of
seven years to research the impact alcohol has on CD4+ cell levels and overall disease
progression. Longitudinal regression models were used to try and find a correlation
between the consumption of alcohol and the progression of HIV. Patients were
interviewed and given questionnaires, and CD4+ cell levels and viral load levels were
checked in the medical record. The results showed that thirty percent of patients were
heavy alcohol drinkers, ten percent were moderate alcohol drinkers, and fifty-nine
percent abstained from drinking alcohol. It was found that the consumption of alcohol
affected those patients who were not on HAART because they had lower CD4+ cells.
However, patients who were on HAART had CD4+ cells levels higher than those patients
not on HAART. This study showed the possible correlation between the progression of
HIV in patients who are not on HAART and found that CD4+ cell levels were lower in
patients who drank alcohol when not on HAART (Samet et al., 2007).
The consumption of alcohol likely plays a critical role when it comes to
adherence rates to HAART, the progression of HIV, the effects on CD4+ cells and viral
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load, and for the increase in adverse effects such as drug toxicity (Bryant et al., 2006). In
order to improve the treatment of HIV/AIDS, patients should be thoroughly assessed for
alcohol use, support services should be used to increase adherence rates, and other factors
should be researched to see if the cause of non-adherence is multi-factorial. Overall,
prevention strategies should be the most important focus for stopping the spread of HIV.
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Chapter Five: Discussion
Human immunodeficiency virus has been around since about the 1800’s, its
questioning interactions with alcohol and HAART have only been researched since
around the late 90’s. Since then, alcohol has been seen as a significant factor in nonadherence to HAART in patients with HIV. Also, it appears to be a factor in the effects
on CD4+ cells and HIV RNA levels causing early mortality. Overall, it is still not a
definitive cause of both non-adherence and early mortality in patients with HIV on
HAART.
Although research shows a strong correlation between the consumption of alcohol
with HAART non-adherence and early mortality, it is still inconclusive. There were a
variety of measurements used in the studies and it cannot be said if alcohol is the primary
or exact factor to cause such an effect on CD4+ cells and viral load in patients with HIV
on HAART. One thing that was seen in all the studies is that there is no definitive
assessment in patients on HAART when it comes to the consumption of alcohol and drug
abuse. In order to help with adherence to HAART, healthcare providers should focus on
the assessment of alcohol use in patients by asking for a thorough history of alcohol use
and making sure to not misinterpret this information. A distinction needs to be made in
the responses and what the patient may mean by "a few drinks". By performing thorough
alcohol use assessments, healthcare providers can help adherence rates and can
potentially prevent the progression of HIV in patients on HAART.
Another result shown in the studies was that non-adherence to HAART was
caused by more than just alcohol use. Many factors contributed to non-adherence rates
such as stress, forgetting to take HAART, having children, having partners, and even
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feeling that taking HAART would not delay the progression of HIV. All of these factors
should be further researched to find why there is such a strong correlation with nonadherence to HAART. Also, the exact causes for the effects of alcohol on CD4+ cells are
still undetermined and should be further researched to pinpoint a more exact reason for a
decrease in CD4+ cells when drinking alcohol on HAART.
Although research is only beginning to surface about the interactions between the
consumption of alcohol and non-adherence to HAART, there are still many gaps in the
research. Many factors need to be researched to find the exact mechanism in which nonadherence, disease progression, and early mortality occurs. Early and thorough
assessment of alcohol use should be a priority in patients on HAART. Patients should be
taught about the possible effects alcohol has on HAART, and referral to support groups
should be used to help patients increase adherence rates. Also, patients should book
follow-up appointments with healthcare providers to prevent complications. Lastly,
preventative strategies should be formed to decrease the spread of HIV/AIDS in the
United States.
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Appendix A
Summary of Articles Reviewed; Ordered by Alphabetical Order
Source

Purpose

Population

Study

Results

Baum et al., To see if the
2010
consumption of
alcohol cause
the progression
of HIV through
non-adherence.

231 HIV +
patients

Prospective
Longitudinal
Study

Frequent alcohol
drinkers are more
likely to be nonadherent to HAART,
which could lead to
disease progression in
patients with HIV.

Braithwaite
et al., 2005

To determine if
there is a
relationship
between the
consumption of
alcohol and nonadherence.

2,702 HIV
+ Veterans
in Care

Observational
Study,
Veterans Aging
Cohort Study

There is a relationship
between alcohol
consumption and
non-adherence as
binge drinkers were
non-adherent 11% on
days of drinking
versus abstainers who
were non-adherent
only 2.4% of time
during reported days.

Braithwaite
et al., 2007

To see if alcohol
affects survival
of patients with
HIV through
non-adherence
of HAART
therapy

2,702 HIV
+ patients

Large
Observational
Cohort

Hazardous alcohol
consumption had a
major effect of
survival by
decreasing overall
survival by three
years and those who
are non-hazardous
drinkers, survival was
decreased by about
one year.
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Source

Purpose

Population

Study

Results

Braithwaite
et al., 2008

To see if the
consumption of
alcohol is
correlated with
non-adherence to
HAART therapy
in patients with
HIV.

1,529 HIV
+ Patients

Cross
Sectional
Analysis

Non-adherence to
HAART therapy
was significantly
associated with the
consumption of
alcohol.

Chander et
al., 2006

To see the effects
of the
consumption of
alcohol on
adherence.

1,711 HIV+
Patients

Observational
Clinical
Cohort

Hazardous drinking
was associated with
non-adherence to
HAART therapy
compared to
abstainers.

To measure
adherence to
HAART therapy,
and to find
underlying reasons
why nonadherence occurs
in patients with
HIV.

75 HIV +
Patients

CrossSectional
Survey

Patients who were
non-adherent were
most likely
consuming alcohol,
working away from
home, or enrolling
in clinical trials to
gain access to
medications.

Chesney et
al., 2000
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Source

Purpose

Conigliaro
et al., 2003

To find and
describe the
correlation of
alcohol
consumption and
the progression of
HIV.

881 HIV+
Veterans

To find a
correlation
between the
consumption of
alcohol and nonadherence to
HAART therapy.

212 HIV+
Patients

Cook et
al., 2001

Finucane To follow up on
et al., 2007 patients to see if
there was an
association of
consuming alcohol
and disease
progression in
patients with HIV.

Golin et
al., 2002

To see if there was
an association
between alcohol
consumption and
medication nonadherence.

Population

197 HIV +
Patients

117 HIV +
Patients

32

Study
Prospective
Cohort

Results
Veterans who were
binge or hazardous
drinkers were
associated with
disease progression
in HIV.

Cross Sectional Medication nonSurvey
adherence was
related to and seen
more in patients
who reported
hazardous or binge
drinking.

Secondary
analysis of a
longitudinal
cohort.

Patients who are
infected with HIV
and consume
alcohol are not fully
adherent to HAART
therapy and have
higher viral load
levels which lead to
the progression of
HIV.

Prospective
Observational
Cohort

Patients who drank
alcohol were
adherent to 66% of
the doses compared
to being adherent
74% with nondrinkers.

Source

Purpose

Population

Hendershot
et al., 2009

To evaluate the
findings across
studies of the
association of
alcohol and nonadherence in
patients with
HIV.

Over 20,000
HIV +
Participants

MetaAnalysis

There is a significant
association between
both the consumption
of alcohol and nonadherence in patients
with HIV, which
could lead to overall
disease progression in
patients.

Hicks et al.,
2007

To the effects of
hazardous or
binge drinking
on adherence to
HAART.

659 HIV+
Patients

CrossSectional

Hazardous or binge
drinkers were less
likely to be adherent
than former drinkers
or never drinkers.

Lehavot et
al., 2001

To examine the
impact of
alcohol on
HAART nonadherence

224 HIV +
Patients

Longitudinal
Random
Control Trial

Consuming alcohol is
negatively associated
with adherence to
HAART in patients
with HIV.

Lucas et al.,
2002

To assess the
association with
drinking alcohol
and nonadherence.

695 HIV+
Patients

Prospective
Cohort

Those who drank
alcohol were
correlated with nonadherence to HAART
therapy, where as
those who quit
drinking were
correlated with
adherence
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Study

Results

Source

Purpose

Population

Study

Results

Murphy
et al.,
2002

To find what
causes nonadherence to
HAART therapy
with women with
children.

52 HIV +
Cross sectional
Women with data used from a
Children
Prospective
Observational
Cohort

Adherence rates
were found to be
43%-56% due to
multiple factors
such as consuming
alcohol, stress,
partners, and
children.

Neblett
et al.,
2011

To see if the
consumption of
alcohol was related
to earlier death in
women on
combination
antiretroviral
therapy.

1,030 HIV +
women

Observational
Cohort

Hazardous alcohol
consumption was
associated with
earlier death in
women diagnosed
with HIV on
antiretroviral
therapy.

Samet et
al., 2003

To see if there is a
relationship
between the
consumption of
alcohol and the
progression of
HIV.

349 HIV+
Patients

Cross-Sectional
Analysis

Patients who drink
alcohol have low
CD4+ levels which
may have a
significant impact
on the progression
of HIV.

Samet et
al., 2004

To find an
association
between the
consumption of
alcohol and
adherence HAART
therapy.

349 HIV+
Patients

Prospective
Cohort

Any amount of
alcohol use is
related to nonadherence to
HAART Therapy in
patients with HIV.
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Source

Purpose

Population

Samet et
al., 2007

To assess the
correlation between
alcohol consumption
and the progression
of HIV.

595 HIV+
Patients

Two
Prospective
Cohorts

Consuming alcohol
has a negative impact
on patients not on
HAART because it
lowers CD4+ levels.

Tucker
et al.,
2003

To investigate the
association of
HAART nonadherence with the
consumption of
alcohol.

1,910 HIV +
Patients on
HAART

Prospective
Cohort

Moderate to heavy
drinkers were more
likely to be nonadherent than those
who did not drink
alcohol.
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Study

Results

